Since January 2024, only 0.2% of people trying to quit smoking have used it (the same proportion that used it in 2018, when ...

Pfizer, Inc. (PFE) stock still looks cheap ahead of its upcoming Aug. 5 Q2 earnings release. Moreover, investors can make extra income by selling out-of-the-money (OTM) put options. This article ...

Income-focused investors actively pursuing high yielders should understand what they stand to sacrifice by reaching for a ...

According to the European Union, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared ...

Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In 2025, the Depo-Provera lawsuit is real and legitimate. Millions have used it — but the risk of brain tumors was only ...

With a market cap of $138.2 billion, Pfizer Inc. (PFE) is a leading global biopharmaceutical company headquartered in New ...

Urologic cancers, which include prostate, bladder, and kidney malignancies, pose significant global health challenges due to ...

I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.

Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 ...